JP2004510772A5 - - Google Patents

Download PDF

Info

Publication number
JP2004510772A5
JP2004510772A5 JP2002532439A JP2002532439A JP2004510772A5 JP 2004510772 A5 JP2004510772 A5 JP 2004510772A5 JP 2002532439 A JP2002532439 A JP 2002532439A JP 2002532439 A JP2002532439 A JP 2002532439A JP 2004510772 A5 JP2004510772 A5 JP 2004510772A5
Authority
JP
Japan
Prior art keywords
groups
pyrrolo
thienyl
formula
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002532439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004510772A (ja
JP4927306B2 (ja
Filing date
Publication date
Priority claimed from EP00810886A external-priority patent/EP1193267A1/en
Application filed filed Critical
Publication of JP2004510772A publication Critical patent/JP2004510772A/ja
Publication of JP2004510772A5 publication Critical patent/JP2004510772A5/ja
Application granted granted Critical
Publication of JP4927306B2 publication Critical patent/JP4927306B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002532439A 2000-09-27 2001-09-27 タンパク質Ｊｕｎ−キナーゼのインヒビターとしての医薬的活性親水性スルホンアミド誘導体 Expired - Fee Related JP4927306B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00810886A EP1193267A1 (en) 2000-09-27 2000-09-27 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases
EP00810886.2 2000-09-27
PCT/IB2001/001771 WO2002028856A1 (en) 2000-09-27 2001-09-27 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases

Publications (3)

Publication Number Publication Date
JP2004510772A JP2004510772A (ja) 2004-04-08
JP2004510772A5 true JP2004510772A5 (enExample) 2012-01-19
JP4927306B2 JP4927306B2 (ja) 2012-05-09

Family

ID=8174936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002532439A Expired - Fee Related JP4927306B2 (ja) 2000-09-27 2001-09-27 タンパク質Ｊｕｎ−キナーゼのインヒビターとしての医薬的活性親水性スルホンアミド誘導体

Country Status (8)

Country Link
US (1) US20040077632A1 (enExample)
EP (2) EP1193267A1 (enExample)
JP (1) JP4927306B2 (enExample)
AU (2) AU2001287990B2 (enExample)
CA (1) CA2421417A1 (enExample)
ES (1) ES2392039T3 (enExample)
IL (1) IL154966A0 (enExample)
WO (1) WO2002028856A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1193256A1 (en) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
EP1193268A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
ATE419247T1 (de) * 2001-07-23 2009-01-15 Serono Lab Arylsulfonamidderivate als hemmer c-jun- terminaler kinasen (jnk)
ATE551997T1 (de) 2003-09-12 2012-04-15 Merck Serono Sa Sulfonamid-derivate zur behandlung von diabetes
CA2561907A1 (en) * 2004-04-08 2005-10-20 Applied Research Systems Ars Holding N.V. Composition comprising a jnk inhibitor and cyclosporin
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
WO2007141224A2 (en) * 2006-06-02 2007-12-13 Laboratoires Serono Sa Jnk inhibitors for treatment of skin diseases
WO2010108115A1 (en) * 2009-03-20 2010-09-23 Sanford-Burnham Medical Research Institute Allosteric jnk inhibitors
WO2011060321A1 (en) 2009-11-16 2011-05-19 Chdi, Inc. Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
US8889716B2 (en) 2011-05-10 2014-11-18 Chdi Foundation, Inc. Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
CN112663077B (zh) * 2021-01-11 2022-07-01 陕西师范大学 一种苯并磺内酰胺类化合物的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553414B1 (fr) * 1983-10-18 1986-08-14 Choay Sa Nouveaux benzenesulfonamides n-cyclises, leur procede de preparation et leur utilisation comme substance active de compositions pharmaceutiques
CA2075057A1 (en) 1990-03-15 1991-09-16 Pharmacia & Upjohn Company Llc Therapeutically useful heterocyclic indole compounds
US5106983A (en) 1990-04-30 1992-04-21 The United States Of America As Represented By The Secretary Of The Army Process of making carfentanil and related analgesics
US5238950A (en) * 1991-12-17 1993-08-24 Schering Corporation Inhibitors of platelet-derived growth factor
US5576313A (en) 1994-08-29 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5744320A (en) * 1995-06-07 1998-04-28 Promega Corporation Quenching reagents and assays for enzyme-mediated luminescence
JP2002512625A (ja) * 1997-05-29 2002-04-23 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としての複素環アミド化合物
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
AR019322A1 (es) * 1998-06-18 2002-02-13 Smithkline Beecham Corp Derivados de sulfonilo sustituido por heterociclo-etanodionanilina sustituida por heterociclo, composicion farmaceutica que los contiene y su uso para lamanufactura de un medicamento
PL199236B1 (pl) * 1998-07-08 2008-08-29 Sanofi Aventis Deutschland N-Aryloamidy kwasów sulfonyloaminokarboksylowych podstawionych siarką, sposób ich wytwarzania, środek farmaceutyczny i zastosowanie N-aryloamidów kwasów sulfonyloaminokarboksylowych podstawionych siarką
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
EP1193268A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
EP1193256A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins

Similar Documents

Publication Publication Date Title
JP2004510772A5 (enExample)
CA2359948A1 (en) Triazole compounds with dopamine-d3-receptor affinity
CA2494302A1 (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
WO2003004472A8 (en) Arylamines for the treatment of conditions associated with gsk-3
WO2000046198A8 (en) Anti-inflammatory indole derivatives
JP2002540253A5 (enExample)
Caton et al. Etiology of periodontal diseases
JP2003506345A5 (enExample)
CN1878757A (zh) 吡啶酮衍生物及其应用
CA2379560A1 (en) Purine derivatives inhibitors of tyrosine protein kinase syk
CA2206532A1 (en) Novel amidinonaphthyl derivative or salt thereof
WO2004087698A3 (en) Thiazoles useful as inhibitors of protein kinases
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
CA2408602A1 (en) Phenylglycine derivatives
SI2228064T1 (sl) Farmacevtski sestavek, ki vsebuje glikopirolat in agonist adrenoceptorja beta2
ATE386725T1 (de) Heterocyclylverbindungen
HRP20110295T1 (hr) Agonisti receptora niacina, smjese koje sadržavaju takve spojeve i postupci liječenja
JP2007505105A5 (enExample)
JP2004315386A5 (enExample)
WO2007080270A3 (fr) Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
ATE343384T1 (de) Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
FR2793246B1 (fr) Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2528493A1 (en) Medicinal composition containing triazole compound
Shelke et al. ULTRASOUND MEDIATED SYNTHESIS AND BIOLOGICAL ACTIVITY OF NEW THIAZOLES DERIVATIVE
TH99067S (th) อุปกรณ์ยึดติดผนัง